This Day On The Street
Continue to site right-arrow
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here
Stocks Under $10 with 50-100% upside potential - 14 days FREE!

3 Stocks Under $5 Moving Higher

Stocks in this article: DARA OCLR CHTP

Dara Biosciences

Content on this page requires a newer version of Adobe Flash Player.

Get Adobe Flash player

Dara Biosciences (DARA) is a specialty pharmaceutical company focused on the development and commercialization of oncology treatment and supportive care pharmaceutical products. This stock is trading up 15.2% to 92 cents per share in recent trading.

Today's Range: $0.86-$0.98

52-Week Range: $0.62-$2.77

Volume: 2.5 million

Three-Month Average Volume: 79,554

Shares of Dara Biosciences are exploding higher today after news broke that the Helsinn Group of Switzerland announced that it has entered into an exclusive agreement with Dara for U.S. commercial rights to Gelclair, an FDA-cleared product indicated for the treatment of oral mucositis.

>>5 Oversold Stocks Ready to Bounce

From a technical perspective, DARA is skyrocketing here with monster volume. This move has pushed DARA into breakout territory, since the stock has moved above some near-term overhead resistance levels at 84 to 85 cents per share. At last check, DARA has hit an intraday high of 98 cents and volume is well above its three-month average action of 79,554 shares.

Traders should now look for long-biased trades in DARA once it triggers its next major breakout. That breakout will hit once DARA clears 98 cents and its 200-day moving average of $1.10 with high volume. Look for a sustained move or close above those levels with volume that's near or above 79,554 shares. If that breakout triggers soon, then DARA will have a great chance of re-testing or possibly taking out its next major overhead resistance level at $1.40.

2 of 4

Select the service that is right for you!

Action Alerts PLUS
Try it NOW

Jim Cramer and Stephanie Link actively manage a real portfolio and reveal their money management tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
  • Weekly roundups
TheStreet Quant Ratings
Try it NOW
Only $49.95/yr

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
  • Upgrade/downgrade alerts
Stocks Under $10
Try it NOW

David Peltier, uncovers low dollar stocks with extraordinary upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
  • Weekly roundups
Dividend Stock Advisor
Try it NOW

Jim Cramer's protege, David Peltier, identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Alerts when market news affect the portfolio
  • Bi-weekly updates with exact steps to take - BUY, HOLD, SELL
Real Money Pro
Try it NOW

All of Real Money, plus 15 more of Wall Street's sharpest minds delivering actionable trading ideas, a comprehensive look at the market, and fundamental and technical analysis.

Product Features:
  • Real Money + Doug Kass Plus 15 more Wall Street Pros
  • Intraday commentary & news
  • Ultra-actionable trading ideas
Options Profits
Try it NOW

Our options trading pros provide daily market commentary and over 100 monthly option trading ideas and strategies to help you become a well-seasoned trader.

Product Features:
  • 100+ monthly options trading ideas
  • Actionable options commentary & news
  • Real-time trading community
  • Options TV
To begin commenting right away, you can log in below using your Disqus, Facebook, Twitter, OpenID or Yahoo login credentials. Alternatively, you can post a comment as a "guest" just by entering an email address. Your use of the commenting tool is subject to multiple terms of service/use and privacy policies - see here for more details.
Submit an article to us!


DOW 17,959.44 +154.64 0.87%
S&P 500 2,078.54 +7.89 0.38%
NASDAQ 4,781.4240 +16.0440 0.34%

Brokerage Partners

Rates from

  • Mortgage
  • Credit Cards
  • Auto

Free Newsletters from TheStreet

My Subscriptions:

After the Bell

Before the Bell

Booyah! Newsletter

Midday Bell

TheStreet Top 10 Stories

Winners & Losers

Register for Newsletters
Top Rated Stocks Top Rated Funds Top Rated ETFs